News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
688,452 Results
Type
Article (39337)
Company Profile (282)
Press Release (648833)
Section
Business (204076)
Career Advice (2007)
Deals (35408)
Drug Delivery (89)
Drug Development (80896)
Employer Resources (168)
FDA (16108)
Job Trends (14817)
News (344913)
Policy (32469)
Tag
Academia (2542)
Alliances (49232)
Alzheimer's disease (1257)
Approvals (16055)
Artificial intelligence (144)
Bankruptcy (352)
Best Places to Work (11583)
Biotechnology (200)
Breast cancer (189)
Cancer (1357)
Cardiovascular disease (110)
Career advice (1673)
Cell therapy (276)
Clinical research (64688)
Collaboration (471)
Compensation (257)
COVID-19 (2551)
C-suite (108)
Data (1382)
Diabetes (167)
Diagnostics (6184)
Earnings (84910)
Employer resources (146)
Events (110064)
Executive appointments (382)
FDA (16762)
Funding (421)
Gene therapy (195)
GLP-1 (594)
Government (4339)
Healthcare (18704)
Infectious disease (2643)
Inflammatory bowel disease (111)
Interviews (311)
IPO (16341)
Job creations (3629)
Job search strategy (1427)
Layoffs (416)
Legal (7864)
Lung cancer (197)
Lymphoma (96)
Manufacturing (203)
Medical device (13222)
Medtech (13227)
Mergers & acquisitions (19213)
Metabolic disorders (442)
Neuroscience (1577)
NextGen Class of 2024 (6508)
Non-profit (4471)
Northern California (1678)
Obesity (254)
Opinion (183)
Patents (116)
People (56516)
Phase I (20119)
Phase II (28489)
Phase III (21240)
Pipeline (511)
Postmarket research (2561)
Preclinical (8558)
Radiopharmaceuticals (236)
Rare diseases (259)
Real estate (5898)
Regulatory (21665)
Research institute (2316)
Resumes & cover letters (349)
Southern California (1451)
Startups (3565)
United States (15024)
Vaccines (565)
Weight loss (179)
Date
Today (146)
Last 7 days (574)
Last 30 days (2521)
Last 365 days (35340)
2024 (34852)
2023 (40098)
2022 (51207)
2021 (55748)
2020 (54127)
2019 (46594)
2018 (35059)
2017 (32140)
2016 (31517)
2015 (37579)
2014 (31362)
2013 (26401)
2012 (28619)
2011 (29313)
2010 (27361)
Location
Africa (713)
Arizona (195)
Asia (37292)
Australia (6098)
California (3772)
Canada (1432)
China (300)
Colorado (170)
Connecticut (176)
Europe (80000)
Florida (530)
Georgia (133)
Illinois (381)
Indiana (223)
Maryland (622)
Massachusetts (2939)
Michigan (170)
Minnesota (287)
New Jersey (1089)
New York (1070)
North Carolina (737)
Northern California (1678)
Ohio (145)
Pennsylvania (916)
South America (1092)
Southern California (1451)
Texas (541)
Utah (105)
Washington State (397)
688,452 Results for "microbiologics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Department of Immunology, Institute of Microbiology, Bulgarian Academy of Sciences and Enzolytics, Inc. Execute Three Year Agreement
September 9, 2024
·
8 min read
Press Releases
Microbiologics Acquires SensID, Expanding Expertise in Diagnostic Quality Controls
November 7, 2024
·
4 min read
Press Releases
Clinical Microbiology Market Size to Reach USD 8.34 Billion by 2034
December 13, 2024
·
1 min read
Microbiology Testing Market Experiencing Rapid Growth
The global microbiology testing market size was valued at USD 5.33 billion in 2023 and it is expected to surpass around USD 12.72 billion by 2033 with a CAGR of 9.12% from 2024 to 2033 due to the increasing demand for genetic testing services.
April 1, 2024
·
14 min read
Qihan Biotech Announces Publication in Microbiology Spectrum on CRISPR-Cas Multiplexed Genome Editing for Reducing African Swine Fever Virus
Hangzhou Qihan Biotech Co., Ltd. announced its groundbreaking research titled “Testing Multiplexed anti-ASFV CRISPR-Cas9 in Reducing African Swine Fever Virus” in Microbiology Spectrum, an academic journal of the American Society for Microbiology.
June 18, 2024
·
4 min read
Clinical Microbiology Market is Experiencing Significant Growth
The global clinical microbiology market size was estimated at around USD 4.58 billion in 2023 and it is projected to hit around USD 7.73 billion by 2033.
March 27, 2024
·
10 min read
Microbiology Reagents Market Latest Trends and Forecast From 2024-2031
According to a new report by Insight Ace Analytic, the “Microbiology Reagents Market” in terms of revenue was estimated to be worth $2.88 Bn in 2023 and is poised to reach $4.57 Bn by 2031, growing at a CAGR of 6.17% from 2024 to 2031.
April 29, 2024
·
6 min read
Genetown
Paratek Pharmaceuticals Presenting New Data from NUZYRA® (Omadacycline) and Investigator-Initiated Pre-Clinical Studies at European Society of Clinical Microbiology & Infectious Diseases Global (ESCMID Global) 2024
Paratek Pharmaceuticals, Inc. today announced that three new pre-clinical studies with NUZYRA ® (omadacycline) will be presented at European Society of Clinical Microbiology & Infectious Diseases Global (ESCMID Global, formerly ECCMID).
April 18, 2024
·
4 min read
Rapid Microbiology Testing Market Size is Expanding to USD 12.37 Billion by 2033
The global rapid microbiology testing market was valued at 5.2 billion in 2022 and is anticipated to reach around 12.37 billion by 2032, expanding at a CAGR of 9.1% from 2023 to 2032.
April 12, 2024
·
9 min read
Pharm Country
SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
SCYNEXIS, Inc. (NASDAQ: SCYX) today announced the presentation of preclinical efficacy data on its second-generation fungerp candidate SCY-247 at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Barcelona, Spain from April 27-30, 2024.
April 9, 2024
·
5 min read
1 of 68,846
Next
